Related Experiment Video
Updated: May 13, 2025

Author Spotlight: An Antimicrobial Fabric Using Nano-Herbal Encapsulation of Essential Oils
Published on: April 7, 2023
Antimicrobial Effects of Kelisha Capsule on Escherichia coli Induced Diarrhea in Mice
Guolin Shi1,2, Xiao Lu2, Guowei Wang1
1Department of Ultrasound in Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310009, People's Republic of China.
Background:
Kelisha capsule (KLSC), listed in the Chinese Pharmacopoeia, has been employed for the treatment of infectious diarrhea. Nevertheless, the precise mechanism of KLSC remains to be elucidated.
Aim Of The Study:
This work was to investigate the antibacterial mode and therapeutic mechanism of KLSC towards E. coli infected diarrhea.
Materials And Methods:
HPLC identified the primary chemical constituents of KLSC. A model of diarrhea was induced via E. coli injection. The impact of KLSC on E. coli-induced diarrhea was evaluated using a diarrhea score in Babl/c mice. The integrity of the intestinal barrier was assessed through staining and measuring levels of specific proteins. Furthermore, immunofluorescence staining was conducted to identify tight junction proteins in the small intestinal tissue. The full-length 16S rRNA was used to examine gut microbiota. Network pharmacology, molecular docking, and molecular dynamic simulation were used to investigate the impact of KLSC on diarrhea-related inflammation and quantify the expression levels of IL-6 and TNF-α in the blood and small intestine. The in vivo antibacterial activity and mode of action of KLSC were also investigated using IVIS imaging, transmission electron microscopy, scanning electron microscopy, and molecular dynamic simulation.
Results:
KLSC exhibited a positive effect on E. coli infected diarrhea. The content of IL-6 and TNF-α in mice with KLSC was significantly reduced. Additionally, KLSC could restore the intestinal barrier function by reversing small intestine structure and up-regulating the expression of tight junction proteins. The KLSC significantly inhibit pathogenic bacteria and restore the gut microbiota diversity. IVIS Imaging System was visually observed significant antibacterial efficacy of KLSC in vivo. The KLSC disrupted the cell membrane system of E. coli through the interaction between bioactive molecule and bilayer.
Conclusion:
KLSC normalized the gut barrier function, reshaped gut microbiota balance, suppressed the inflammatory pathways, and inhibited the bacterial activity, thereby relieving the diarrhea caused by E. coli.
More Related Videos
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
09:09High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Antibiotic Selection